This website is intended for users outside of the US and UK.

how is hereditary angioedema diagnosed?


When diagnosing hereditary angioedema (HAE), a combination of factors should be considered, including symptoms, family history, and laboratory testing.1


HAE test iconTesting for C1-INH deficiency or dysfunction

Patients suspected of having HAE Type 1 or Type 2 should be assessed for blood levels of C1-INH function, C1-INH protein, and C4. Using complement testing, a patient’s peripheral blood test will show low C4 levels, in addition to low C1-INH activity or levels. If any of the levels are abnormally low, the tests should be repeated to confirm the diagnosis.1,3


Other forms of HAE have been described that do not involve mutations of C1-INH, and are rare. However, it is possible for patients with this type of HAE to have clinical symptoms that are indistinguishable from Types 1 and 2 and have normal plasma levels and functional C1-INH. This has been referred to as Type 3 HAE.7


delays to diagnosis of hereditary angioedema

HAE is often misdiagnosed, even among patients with a family history5:

  • In a real-world registry study of patients with HAE Type 1 or Type 2, almost half of patients had initially received 1 or more misdiagnoses (185/418)


  • Patients who received a misdiagnosis experienced a mean diagnostic delay of 15 years5


  • In general, misdiagnosis can result in increased health resource use, including unnecessary abdominal surgeries and increased risk of death from laryngeal attacks6-8


spotblock image good to know

Genetic testing increases diagnostic reliability in children. It may be helpful if the mutation of the parent is known, or if biochemical measurements are inconclusive.2,3

sign up to stay in the know

You must be logged in to submit the form.

Terms + Conditions


This website is intended for users outside of the US and UK.
References: 1. Maurer M, Magerl M, Ansotegui I, et al. The international WAO/EAACI guideline for the management of hereditary angioedema—the 2017 revision and update. Allergy. 2018. doi:10.1111/all.13384. 2. Zuraw BL. Clinical Practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036. 3. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602-616. 4. Zuraw B. Hereditary angioedema with normal C1 inhibitor. Four types and counting. J Allergy Clin Immunol. 2018;141(3): 884-885. 5. Zanichelli A, Longhurst HJ, Maurer M, et al. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. Ann Allergy Asthma Immunol. 2016;117(4):394-398. 6. Patel N, Suarez LD, Kapur S, Bielory L. Hereditary angioedema and gastrointestinal complications: an extensive review of the literature. Case Reports Immunol. 2015;2015:925861. 7. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692-697. 8. Longhurst H, Bygum A. The humanistic, societal, and pharmaco-economic burden of angioedema. Clin Rev Allerg Immunol. 2016;51(2):230-239.